IRIS
LARUSSA, Tiziana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.910
AS - Asia 1.122
EU - Europa 736
SA - Sud America 175
Continente sconosciuto - Info sul continente non disponibili 120
AF - Africa 17
OC - Oceania 11
Totale 4.091
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.837
SG - Singapore 463
CN - Cina 296
IT - Italia 260
BR - Brasile 137
DE - Germania 136
IN - India 125
GB - Regno Unito 106
VN - Vietnam 83
FI - Finlandia 69
SE - Svezia 56
CA - Canada 47
IR - Iran 38
NL - Olanda 26
HK - Hong Kong 23
TR - Turchia 19
AR - Argentina 18
MX - Messico 14
RU - Federazione Russa 14
TW - Taiwan 11
AU - Australia 10
BD - Bangladesh 10
FR - Francia 10
PL - Polonia 10
ID - Indonesia 8
UA - Ucraina 8
IQ - Iraq 7
EC - Ecuador 6
RO - Romania 6
UZ - Uzbekistan 6
ES - Italia 5
IL - Israele 5
PY - Paraguay 5
ZA - Sudafrica 5
AT - Austria 4
CL - Cile 4
EU - Europa 4
PH - Filippine 4
PK - Pakistan 4
SA - Arabia Saudita 4
AL - Albania 3
CZ - Repubblica Ceca 3
JP - Giappone 3
LT - Lituania 3
MA - Marocco 3
NI - Nicaragua 3
SK - Slovacchia (Repubblica Slovacca) 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AO - Angola 2
BE - Belgio 2
BH - Bahrain 2
CH - Svizzera 2
CU - Cuba 2
EG - Egitto 2
HU - Ungheria 2
JM - Giamaica 2
LB - Libano 2
PS - Palestinian Territory 2
RS - Serbia 2
UY - Uruguay 2
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BM - Bermuda 1
CI - Costa d'Avorio 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GF - Guiana Francese 1
GR - Grecia 1
HN - Honduras 1
KE - Kenya 1
KW - Kuwait 1
LK - Sri Lanka 1
MD - Moldavia 1
MG - Madagascar 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
QA - Qatar 1
SV - El Salvador 1
VE - Venezuela 1
Totale 3.977
Salva come PNG Salva come JPEG
Città #
San Jose 366
Ashburn 166
Chandler 152
Singapore 145
Munich 114
Dallas 107
Chicago 93
Santa Clara 93
London 86
Hefei 79
Bengaluru 77
Council Bluffs 75
Princeton 69
Lawrence 68
Milan 67
Beijing 54
Helsinki 47
Wilmington 41
Catanzaro 37
Ho Chi Minh City 32
Ottawa 30
Los Angeles 22
Des Moines 21
Hong Kong 21
São Paulo 20
Hanoi 19
Phoenix 19
Redwood City 19
Mumbai 18
New York 14
Turku 14
Mendicino 12
Shanghai 11
Guangzhou 10
Rome 10
Istanbul 9
Praia A Mare 9
Boardman 8
The Dalles 8
Collegeville 7
Orem 7
Pune 7
Tehran 7
Chennai 6
Cittanova 6
Redmond 6
San Francisco 6
Shenzhen 6
Warsaw 6
Brooklyn 5
Curitiba 5
Da Nang 5
Hanover 5
Jyväskylä 5
Miami 5
Montreal 5
Norwalk 5
Rio de Janeiro 5
Belo Horizonte 4
Boston 4
Brasília 4
Buffalo 4
Clearwater 4
Frankfurt am Main 4
Horia 4
Mexico City 4
Santo André 4
Selargius 4
Silea 4
Taipei 4
Toronto 4
Atlanta 3
Bade District 3
Bari 3
Benevento 3
Bratislava 3
Campinas 3
Cape Town 3
Charlotte 3
Dhaka 3
Fremont 3
Jiaxing 3
Kahramanmaraş 3
Karachi 3
Managua 3
Miguel Hidalgo 3
Nanjing 3
Naples 3
Paris 3
Quito 3
Rende 3
Riyadh 3
Salt Lake City 3
San Juan 3
Stockholm 3
São Bernardo do Campo 3
Tashkent 3
Tel Aviv 3
Vienna 3
Wuxi 3
Totale 2.510
Salva come PNG Salva come JPEG
Nome #
Adverse drug reactions during biologic therapy in inflammatory disease: real life data from the pharmacovigilance project in the Calabria region 263
Dietary polyphenolsand non-alcoholic fatty liver disease 112
A Framework for Patient Data Management and Analysis in Randomised Clinical Trials 104
Anxiety and Gastrointestinal Symptoms Related to COVID-19 during Italian Lockdown 86
Efficacy of Mediterranean diet and antioxidants in overweight patients with non-alcoholic fatty liver disease. 84
Barriers And Facilitators In Conducting Clinical Trials In Inflammatory Bowel Disease: A Monocentric Italian Survey. 78
COVID-19 and Inflammatory Bowel Disease: Patient Knowledge and Perceptions in a Single Center Survey 78
The role of gluten-free diet in nonalcoholic fatty liver disease development 78
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 77
Safety profile of intravenous iron in inflammatory bowel disease: an up-to-date overview 71
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study 70
Oleuropein Decreases Cyclooxygenase-2 and Interleukin-17 Expression and Attenuates Inflammatory Damage in Colonic Samples from Ulcerative Colitis Patients 69
SARS-CoV-2 Spread Dynamics in Italy: The Calabria Experience 69
Real-life burden of adverse reactions to biological therapy in inflammatory bowel disease: a single-centre prospective case series. 68
Long-term, Real-life, Observational Study in Treating Outpatient Ulcerative Colitis with Golimumab 66
Gut microbiota and non-alcoholic fatty liver disease 66
Enhanced expression of indole amine 2,3-dioxygenase (IDO) in Helicobacter pylori-infected human gastric muciosa downregulates interleukin (IL)-17 and upregulates IL-4 production. 65
Effectiveness and safety of adalimumab to treat outpatient ulcerative colitis: A real-life multicenter, observational study in primary inflammatory bowel disease centers 62
Enhanced expression of indoleamine 2,3-dioxygenase (IDO) in Helicobacter pylori-infected human gastric mucosa modulates TH1/TH2 patway and interleukin (IL)-17 production. 61
Effect of selective cyclooxygenase (Cox)-2 Inhibition and proton pump inhibitors (PPI) therapy on TH1 immune response in human gastric mucosa 61
Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic. 59
Long-term real-life efficacy and safety of infliximab and adalimumab in the treatment of inflammatory bowel diseases outpatients 57
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 57
Helicobacter pylori and T Helper Cells: Mechanisms of Immune Escape and Tolerance 57
Effectiveness and Safety of Golimumab in Treating Outpatient Ulcerative Colitis: A Real-Life Prospective, Multicentre, Observational Study in Primary Inflammatory Bowel Diseases Centers 57
Bone mineralization in celiac disease 56
Decreased circulating interleukin-33 concentration in Helicobacter pylori-infected patients with peptic ulcer: Evaluation of its association with a cytokine gene polymorphism, gender of patients and bacterial virulence factor CagA 56
Oleuropein decreases interleukin-17 and attenuates inflammatory damage in colonic mucosa from ulcerative colitis patients 54
Enhanced activation of cyclooxygenase-2 down-regulates Th1 signaling pathway in Helicobacter pylori-infected human gastric mucosa 52
Diminished circulating concentration of interleukin-35 in Helicobacter pylori-infected patients with peptic ulcer: Its association with FOXP3 gene polymorphism, bacterial virulence factor CagA, and gender of patients 51
Multifaceted pathogenesis of liver steatosis in inflammatory bowel disease: A systematic review 51
Reduced bone mineral density is frequent in treated adult coeliac disease not with standing complete normalization of duodenal lesions. 48
Lactobacillus paracasei F19 versus placebo for the prevention of proton pump inhibitor-induced bowel symptoms: a randomized clinical trial 48
Effect of selective cyclooxygenase (COX)-2 inhibition and proton pump inhibitors (PPI) therapy on TH1 immune response in human gastric mucosa 47
Real-life efficacy and safety of Ustekinumab as second- or third-line therapy in Crohn's disease: results from a large Italian cohort study 47
Crohn disease: Identification, diagnosis, and clinical management. 47
Self-Prescribed Dietary Restrictions are Common in Inflammatory Bowel Disease Patients and Are Associated with Low Bone Mineralization 46
Very low vitamin D level is an independent risk factor for bone demineralization in IBD patients 46
Short-term Therapy with Celecoxib and Lansoprazole Modulates Th1/Th2 Immune Response in Human Gastric Mucosa 46
Downregulation of Interleukin- (IL-) 17 through Enhanced Indoleamine 2,3-Dioxygenase (IDO) Induction by Curcumin: A Potential Mechanism of Tolerance towards Helicobacter pylori 46
Trends and characteristics associated with dietary triggers and psychological distress in patients with irritable bowel syndrome: a cross-sectional study 45
Vedolizumab is effective and safe in real-life treatment of inflammatory bowel diseases outpatients: A multicenter, observational study in primary inflammatory bowel disease centers 45
Infliximab biosimilar CT-P13 is effective and safe in treating inflammatory bowel diseases: a real-life multicenter, observational study in Italian primary inflammatory bowel disease centers 45
Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy 44
Epidemiology of Helicobacter pylori infection: the Sorbo San Basile study. 43
Enhanced expression of indoleamine 2,3-dioxygenase in Helicobacter pylori-infected human gastric mucosa modulates Th1/Th2 pathway and interleukin 17 production 42
Enhanced Expression of Indoleamine 2,3-Dioxygenase (IDO) in Helicobacter pylori-Infected Human Gastric Mucosa Modulates TH1/Th2 Pathway and Interleukin (IL)-17 Production. 42
Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to standard pharmeceutical treatment: a double-blind, randomized, placebo-controlled study 42
Survey on alcohol consumption in a gastroenetrology outpatient center in southern Italy. 42
Living with inflammatory bowel diseases: patients’ perceptions and unmet needs from a single-center Italian survey 40
High prevalence of polymorphism and low activity of thiopurine methiltransferase in patients with inflammatory bowel disease. 40
Mediterranean diet and probiotics supplementation to treat non-alcoholic fatty liver disease 40
Gut microbiota in inflammatory bowel disease: a target for therapy not to be missed. 40
Normal Bone Mineral Density Associates with Duodenal Mucosa Healing in Adult Patients with Celiac Disease on a Gluten-Free Diet 39
Potential role of nutraceutical compounds in inflammatory bowel disease 39
Liver Cirrhosis Complications Management At The Emergency Department 39
Increased Indoleamine 2, 3-Dioxygenase expression modulates Th1/Th17/Th22 and Treg pathway in humans with Helicobacter Pylori-Infected gastric mucosa 39
No evidence of circulating autoantibodies against osteoprotegerin in treated celiac patients with low bone mineral density. 38
Potential role of fecal gluten immunogenic peptides to assess dietary compliance in celiac patients 38
SURVEY ON ALCOHOL CONSUMPTION IN A GASTROENTEROLOGY OUTPATIENT CENTER IN SOUTHERN ITALY 37
High Exposure, Spontaneous Clearance, and Low Incidence of Active Helicobacter pylori Infection: The Sorbo San Basile Study 37
T cell subsets play an important role in the determination of the clinical outcome of Helicobacter pylori infection 36
Toll-like receptor 2: An important immunomodulatory molecule during Helicobacter pylori infection 36
The protective effects of resveratrol on ulcerative colitis via changing the profile of Nrf2 and IL-1β protein 36
Nutrigenomics and Nutrigenetics in Metabolic- (Dysfunction) Associated Fatty Liver Disease: Novel Insights and Future Perspectives 36
No evidence of circulating autoantibodies against osteoprotegerin in patients with celiac disease 35
Vitamin D down-regulates the expression of some Th17 cell-related cytokines, key inflammatory chemokines, and chemokine receptors in experimental autoimmune encephalomyelitis 34
Enhanced expression of indoleamine 2,3-dioxygenase in Helicobacter pylori-infected human gastric mucosa modulates Th1/Th2 pathway and interleukin 17 production 33
Use of Complementary and Alternative Medicine by Patients with Irritable Bowel Syndrome According to the Roma IV Criteria: A Single-Center Italian Survey 33
Liver steatosis in celiac disease: the open door 32
OLEUROPEIN EXERTS ANTIOXIDANT ACTIVITY AND REDUCES THE EXPRESSION OF COX-2 AND PROINFLAMMATORY CYTOKINES IN CACO-2 CELLS AND COLONIC MUCOSA FROM ULCERATIVE COLITIS PATIENTS 32
High prevalence of polymorphism and low activity of thiopurine methyltransferase in patients with inflammatory bowel disease. 31
The Reality of Patient-Reported Outcomes of Health-Related Quality of Life in an Italian Cohort of Patients with Inflammatory Bowel Disease: Results from a Cross-Sectional Study 31
From Pre- and Probiotics to Post-Biotics: A Narrative Review. 31
Beneficial effects of coffee in non-alcoholic fatty liver disease: a narrative review 31
Refractory ulcerative colitis complicated by cytomegalovirus infection successfully treated with valganciclovir 30
Olive Tree Biophenols in Inflammatory Bowel Disease: When Bitter is Better 22
Totale 4.091
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.317
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.317
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022229 0 0 0 49 17 4 10 48 22 26 37 16
2022/2023610 138 35 48 41 34 36 7 50 55 96 62 8
2023/2024290 69 20 25 16 10 75 6 15 27 2 9 16
2024/2025884 119 45 43 18 70 121 64 42 159 8 73 122
2025/20261.458 84 185 142 211 188 62 175 105 166 105 28 7
2026/2027339 19 87 194 39 0 0 0 0 0 0 0 0
Totale 4.091